Self-assembling peptide-based hemostatic systems designed to manage bleeding during surgical and clinical procedures. These bioengineered devices provide rapid and effective bleeding control through innovative peptide matrix technology, improving patient outcomes in operative settings.
Manufactured by
3-D Matrix Medical Technology
China
3-D Matrix Medical Technology originated from MIT and holds exclusive global patent rights for self-assembling peptide technology. Listed on Japan's JASDAQ since 2011, headquartered in Tokyo with offices in Boston, Lyon, Singapore, São Paulo, Amsterdam, Hong Kong, and Beijing. The company develops, manufactures, and sells medical devices based on self-assembling peptide materials for hemostasis, regenerative medicine, and drug delivery systems. PuraSinus® is marketed in the US, Europe, Australia, and Hong Kong for hemostasis in solid organ resection and endoscopic procedures.
© 2026 Suplivia · Home · Browse Products